| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |